U-Blot® Research Grade CudarolimabCat. No. WA2644$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade CudarolimabCat. No. WA2644
U-Blot® Research Grade cT84.66Cat. No. WA2643
U-Blot® Research Grade crusekitugCat. No. WA2642
U-Blot® Research Grade CrovalimabCat. No. WA2641
U-Blot® Research Grade CrotedumabCat. No. WA2640
U-Blot® Research Grade CrizanlizumabCat. No. WA2639
U-Blot® Research Grade CrexavibartCat. No. WA2638
U-Blot® Research Grade CrenezumabCat. No. WA2637
U-Blot® Research Grade CrefmirlimabCat. No. WA2636
U-Blot® Research Grade CrebankitugCat. No. WA2635
U-Blot® Research Grade CosibelimabCat. No. WA2634
U-Blot® Research Grade CosfroviximabCat. No. WA2633